Cargando…
In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants
BACKGROUND: Intrinsic pathway of apoptosis is generally mediated by BCL-2 (B cell lymphoma 2) family of proteins; they either induce or inhibit the apoptosis. Overexpression of BCL-2 in cancer cell may lead to delay in apoptosis. BCL-w is the pro-survival member of the BCL-2 family. BCL2L2 gene is p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372248/ https://www.ncbi.nlm.nih.gov/pubmed/35951173 http://dx.doi.org/10.1186/s43141-022-00389-2 |
_version_ | 1784767337779429376 |
---|---|
author | Kumari, Poonam Rameshwari, Rashmi |
author_facet | Kumari, Poonam Rameshwari, Rashmi |
author_sort | Kumari, Poonam |
collection | PubMed |
description | BACKGROUND: Intrinsic pathway of apoptosis is generally mediated by BCL-2 (B cell lymphoma 2) family of proteins; they either induce or inhibit the apoptosis. Overexpression of BCL-2 in cancer cell may lead to delay in apoptosis. BCL-w is the pro-survival member of the BCL-2 family. BCL2L2 gene is present on chromosome number 14 in humans, and it encodes BCL-w protein; BCL-w protein is 193 amino acids residues in length. Interactions among the BCL-2 proteins are very specific. The fate of cell is determined by the ratio of pro-apoptotic proteins to pro-survival proteins. BCL-w promotes cell survival. Studies suggested that overexpression of BCL-w protein is associated with many cancers including DLBCL, BL, colorectal cancers, gastric cancers, and many more. The cause of overexpression is translocations or gene amplification which will subsequently result in cancerous activity. PROCESS: For in-silico analysis, BCL2L2 gene was retrieved from UniProt (UniProt ID: Q92843). 54 missense variants have been collected in BCL-w proteins from COSMIC database. Different tools were used to detect the deleteriousness of the variants. RESULT: In silico mutational study reveals how the non-synonymous mutations directly affect the protein’s native structure and its function. Variant mutational analysis with PolyPhen-2 revealed that out of 55 variants, 28 of the missense mutations was probably damaging with a score ranging from 0.9 to 1, while 24 variants were benign with a score ranging from 0 to 0.4. CONCLUSIONS: This in silico work aims to determine how missense mutations in BCL-w protein affect the activity of the protein, the stability of the protein, and to determine the pathogenicity of the variants. Prediction of pathogenicity of variants will reveal if the missense mutation has a damaging effect on the native structure of protein or not. Prediction of protein stability will reveal whether the mutation has a stabilizing or destabilizing effect on the protein. |
format | Online Article Text |
id | pubmed-9372248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-93722482022-08-26 In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants Kumari, Poonam Rameshwari, Rashmi J Genet Eng Biotechnol Research BACKGROUND: Intrinsic pathway of apoptosis is generally mediated by BCL-2 (B cell lymphoma 2) family of proteins; they either induce or inhibit the apoptosis. Overexpression of BCL-2 in cancer cell may lead to delay in apoptosis. BCL-w is the pro-survival member of the BCL-2 family. BCL2L2 gene is present on chromosome number 14 in humans, and it encodes BCL-w protein; BCL-w protein is 193 amino acids residues in length. Interactions among the BCL-2 proteins are very specific. The fate of cell is determined by the ratio of pro-apoptotic proteins to pro-survival proteins. BCL-w promotes cell survival. Studies suggested that overexpression of BCL-w protein is associated with many cancers including DLBCL, BL, colorectal cancers, gastric cancers, and many more. The cause of overexpression is translocations or gene amplification which will subsequently result in cancerous activity. PROCESS: For in-silico analysis, BCL2L2 gene was retrieved from UniProt (UniProt ID: Q92843). 54 missense variants have been collected in BCL-w proteins from COSMIC database. Different tools were used to detect the deleteriousness of the variants. RESULT: In silico mutational study reveals how the non-synonymous mutations directly affect the protein’s native structure and its function. Variant mutational analysis with PolyPhen-2 revealed that out of 55 variants, 28 of the missense mutations was probably damaging with a score ranging from 0.9 to 1, while 24 variants were benign with a score ranging from 0 to 0.4. CONCLUSIONS: This in silico work aims to determine how missense mutations in BCL-w protein affect the activity of the protein, the stability of the protein, and to determine the pathogenicity of the variants. Prediction of pathogenicity of variants will reveal if the missense mutation has a damaging effect on the native structure of protein or not. Prediction of protein stability will reveal whether the mutation has a stabilizing or destabilizing effect on the protein. Springer Berlin Heidelberg 2022-08-11 /pmc/articles/PMC9372248/ /pubmed/35951173 http://dx.doi.org/10.1186/s43141-022-00389-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Kumari, Poonam Rameshwari, Rashmi In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants |
title | In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants |
title_full | In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants |
title_fullStr | In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants |
title_full_unstemmed | In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants |
title_short | In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants |
title_sort | in silico mutational analysis to identify the role and pathogenicity of bcl-w missense variants |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372248/ https://www.ncbi.nlm.nih.gov/pubmed/35951173 http://dx.doi.org/10.1186/s43141-022-00389-2 |
work_keys_str_mv | AT kumaripoonam insilicomutationalanalysistoidentifytheroleandpathogenicityofbclwmissensevariants AT rameshwarirashmi insilicomutationalanalysistoidentifytheroleandpathogenicityofbclwmissensevariants |